Investors didn't show much interest in one Revolution Medicines way or another today. It hasn't moved too much today but is slightly down, it lost -0.05% since yesterday.
Currently RVMD isn't at a clear support/resistance line that seems tradable. Revolution Medicines has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. RVMD might find some support at the 32.78 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Revolution Medicines right now, so not much useful information here. The current Analysts Sentiment Score is 5.96. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Wedbush provided a price target boost of 2.44% to $42.00 from $41.00 on 2024-02-27. Raymond James gave a boost to their price target and moved to $36.00 from $30.00 on 2024-01-16. Bank of America announced an upgrade on 2024-01-05 from Neutral to Buy and moved up their price target to $34.00 which is a 9.68% increase. UBS Group initiated a rating of Buy on 2023-12-20 and provided a price target of $40.00. HC Wainwright announced a lowering of their price target to $28.00 from $32.00 on 2023-11-13. JPMorgan Chase & Co. provided a price target decease of -17.02% to $39.00 from $47.00 on 2023-11-07. Needham & Company LLC announced that they are reiterating a rating of Buy on 2023-11-07 and they set their price target at $36.00. Oppenheimer gave a boost to their price target and moved to $43.00 from $40.00 on 2023-10-23. On 2023-09-21 Stifel Nicolaus increased their price target by 27.03% to $47.00. On 2023-03-01 The Goldman Sachs Group increased their price target by 15% to $23.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| RVMD | 5.96 | 6.54 | 0 | 6.31 | -0.93 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| RVMD | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| RVMD | 6.88 | %9.93148 | 5.1 | -11.682 | 10870000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| RVMD |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 1.01 | 4.90 | 10.72 | 10.16 | 20.33 | 67.85 | 100.31 | 41 | 147.88 | 61.03 | 45.81 | -16715.87 | -11657.75 | 100 | 0 | 6.87902 |
| MDGL | Madrigal Pharmaceuticals, | 0.9 | 5.53 | 14.48 | 60.12 | 40.59 | 55.60 | 77.67 | 64 | 8.74 | 10.72 | 7.70 | 0.00 | -23329.50 | 125 | 0 | 18.5824 |
| KURA | Kura Oncology, Inc. | 0.89 | 7.36 | -32.67 | -39.09 | -48.72 | -49.74 | 12.97 | 59 | -12.34 | -8.94 | -6.18 | -4497.47 | -12834.13 | 0 | 0 | 7.89025 |
| EXAS | Exact Sciences Corp | 0.88 | -0.30 | 6.80 | -23.71 | -14.23 | 12.53 | -19.82 | 5 | 2.94 | 8.45 | 17.92 | -4506.66 | -1214.26 | 0 | 0 | 5.2321 |
| CDLX | Cardlytics, Inc. Common S | 0.87 | 3.42 | 14.24 | -2.72 | 0.51 | -59.90 | -49.81 | 41 | -39.16 | -24.26 | -45.48 | -87992.30 | -2632.75 | 0 | 0 | 7.62234 |
| RCKT | Rocket Pharmaceuticals, I | 0.86 | 10.32 | 3.29 | -19.33 | -25.15 | -32.62 | -36.58 | 29 | -88.38 | -65.83 | -77.27 | -23028.56 | -99.38 | 0 | 0 | 9.12889 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
